Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02715765 · ClinicalTrials.gov registry record · NA
The Use of Transcranial Electrical Stimulation for Hallucinations
A NA study, sponsored by University of Minnesota.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02715765: Clinical Trial NA study, sponsored by University of Minnesota.
NCT02715765 is a NA study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02715765, a NA study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Schizophrenia is a serious mental health disorder that affects approximately 1% of the population. Auditory hallucinations are present in as many as 50-75% of patients with this diagnosis. The hallucinations experienced by patients vary greatly and can severely impact an individual's ability to function on a daily basis. In approximately 25-30% of these patients, medication is an ineffective mechanism for managing these symptoms. These hallucinations are known as medication refractory auditory hallucination (MRAH). For those whose auditory hallucinations do not respond to medication, non-surgical brain stimulation (NBS) has recently shown promise as a therapeutic intervention. Two specific types of NBS, called transcranial direct current stimulation (tDCS) and transcranial random noise stimulation (tRNS), seem particularly well suited to treating MRAH. They have yet to be compared to each other in large samples of patients with MRAH. The goal of the study is to investigate whether tRNS and tDCS are effective in the treatment of MRAH and if one is better than the other when compared directly.
Interventions
- DEVICE Transcranial Direct Current Stimulation
- DEVICE Transcranial Random Noise Stimulation
- DEVICE Transcranial Sham Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-07 |
| Est. Completion | 2016-07 |
| Phase | NA |
Why NCT02715765 stopped before completion
NCT02715765 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Transcranial Direct Current Stimulation is the first listed.
NCT02715765 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02715765 about?
NCT02715765 is a clinical study titled "The Use of Transcranial Electrical Stimulation for Hallucinations". Schizophrenia is a serious mental health disorder that affects approximately 1% of the population. Auditory hallucinations are present in as many as 50-75% of patients with this diagnosis. The hallucinations experienced by patients vary greatly and can severely impact an individual's ability to func...
What is the current status of trial NCT02715765?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2016-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02715765?
The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE), Transcranial Random Noise Stimulation (DEVICE), Transcranial Sham Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02715765?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02715765's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia